News from astrazeneca A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 18, 2018, 07:06 ET US FDA Approves TAGRISSO® (osimertinib) As 1st-Line Treatment For EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO® (osimertinib) for the 1st-line treatment of...


Feb 16, 2018, 11:11 ET US FDA APPROVES IMFINZI® (DURVALUMAB) FOR UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER

AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has...


Jan 10, 2018, 08:00 ET BYDUREON® BCise™ Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes

AstraZeneca today announced that BYDUREON® BCise™ (exenatide extended-release) injectable suspension 2mg is now available in pharmacies across the...


Nov 14, 2017, 18:02 ET FASENRA (benralizumab) Receives US FDA Approval For Severe Eosinophilic Asthma

AstraZeneca (NYSE: AZN) and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration...


Oct 31, 2017, 14:54 ET US FDA APPROVES ASTRAZENECA'S CALQUENCE® (acalabrutinib) FOR ADULT PATIENTS WITH PREVIOUSLY-TREATED MANTLE CELL LYMPHOMA

AstraZeneca and its hematology research and development center of excellence, Acerta Pharma, today announced that the US Food and Drug Administration ...


May 01, 2017, 15:52 ET AstraZeneca's IMFINZI™ (Durvalumab) Receives US FDA Accelerated Approval For Previously Treated Patients With Advanced Bladder Cancer

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has...


Apr 11, 2016, 09:29 ET Eficacia de ceftazidime-avibactam en el tratamiento de bacterias Gram-negativas resistentes a múltiples fármacos

Este comunicado de prensa se ha redactado en inglés. Las traducciones al alemán, francés y español las suministra PRNewswire como servicio a clientes ...


Apr 10, 2016, 08:56 ET L'analyse poolée de sept études cliniques révèle une efficacité constante de la ceftazidime-avibactam dans le traitement des bactéries Gram négatif multi-résistantes

Ce communiqué de presse a été écrit en anglais. Les traductions en allemand, français et espagnol ont été réalisées par PR Newswire pour le confort...


Apr 10, 2016, 08:54 ET Gepoolte Analyse von sieben klinischen Studien ergibt konstante Wirksamkeit von Ceftazidim-Avibactam bei der Behandlung von multiresistenten gramnegativen Bakterien

Diese Pressemitteilung wurde auf Englisch verfasst. Übersetzungen auf Deutsch, Französisch und Spanisch werden von PRNewswire für unsere...


Mar 10, 2016, 07:00 ET AstraZeneca Partners With Dr. Phil To Launch The "ON IT" Movement For People With Type 2 Diabetes

When Dr. Phil McGraw was diagnosed with type 2 diabetes 25 years ago, he made a commitment to get on – and stay on – a healthy path. Now, AstraZeneca ...


Nov 13, 2015, 11:25 ET TAGRISSO™ (osimertinib) (AZD9291) Approved By The US FDA As Treatment For Patients With EGFR T790M Mutation-Positive Metastatic Non-Small Cell Lung Cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO™ (osimertinib) (AZD9291) 80mg once-daily tablets for ...


Sep 25, 2015, 09:52 ET The National Forum for Heart Disease & Stroke Prevention and AstraZeneca Ask You to Join in Raising Awareness of Cholesterol Health with World Heart Day Thunderclap

Cardiovascular disease is a leading cause of death, globally. In the United States, every 33 seconds someone dies of heart disease, making it the...


Sep 03, 2015, 05:49 ET US FDA Approves Expanded Indication For BRILINTA To Include Long-Term Use In Patients With A History Of Heart Attack

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved BRILINTA® (ticagrelor) tablets at a new 60mg dose to be used...


Jun 08, 2015, 09:24 ET Cholesterol Awareness Initiative Makes Its Move Across America

AstraZeneca (NYSE: AZN) is on the road in support of cholesterol education. Earlier this year, the company launched the "Make Your Move Across...


Apr 27, 2015, 03:00 ET Positive Phase-III-Ergebnisse für zwei Antibiotika, Zinforo™▼ und Prüfpräparat Ceftazidime-avibactam, auf führendem Kongress für Infektionskrankheiten vorgestellt

Diese Pressemitteilung wurde auf Englisch verfasst. Übersetzungen auf Deutsch, Französisch und Spanisch werden von PRNewswire für unsere...


Apr 27, 2015, 03:00 ET Résultats de phase III positifs pour deux antibiotiques, Zinforo™▼ et l'expérimental Ceftazidime-Avibactam, présentés à l'occasion d'une conférence de premier plan sur les maladies infectieuses

Ce communiqué de presse a été écrit en anglais. Les traductions en allemand, français et espagnol ont été réalisées par PR Newswire pour le confort...


Apr 27, 2015, 03:00 ET Resultados de fase III positivos para dos antibióticos, Zinforo™▼ y la experimental ceftazidima-avibactam, presentados en la Conferencia de las principales enfermedades infecciosas

Este comunicado de prensa se redactó en inglés. Las traducciones al alemán, francés y español las suministra PR Newswire como servicio a clientes...


Apr 17, 2015, 10:30 ET "Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC

ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable alternative to tumour biopsy IGNITE supports value of EGFR...


Dec 19, 2014, 03:54 ET LYNPARZA(TM) Approved By The US Food and Drug Administration For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-mutations

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA™ (olaparib) capsules. LYNPARZA is the first poly...


Sep 25, 2014, 11:25 ET AstraZeneca Launches New Website for People with Advanced Medullary Thyroid Cancer

In the United States for 2014, about 62,900 new thyroid cancer cases will be diagnosed. Medullary thyroid cancer – a rare form of cancer located in...


Sep 23, 2014, 05:55 ET AstraZeneca Launches Nationwide Photo-Sharing Campaign for Women with Metastatic Breast Cancer

More than 173,000 women in the United States are living with metastatic breast cancer and each has a story to tell. AstraZeneca is launching a...


Sep 16, 2014, 12:50 ET Actor James Van Der Beek and AstraZeneca Join Forces to Educate Families about Influenza

AstraZeneca announced today that it has collaborated with actor and father James Van Der Beek on a campaign to dispel common myths about the flu and...


Jun 20, 2014, 07:05 ET Se demuestra que naloxegol mejora el estreñimiento inducido por opioides en pacientes con dolor crónico

AstraZeneca anunció hoy que el New England Journal of Medicine (NEJM) ha publicado los resultados de dos ensayos pivote en fase III – KODIAC-4 y...


Jun 20, 2014, 04:39 ET Des données publiées dans le New England Journal Of Medicine montrent que le naloxegol agit contre la constipation sous opioïdes chez les patients souffrant de douleurs chroniques

AstraZeneca a annoncé aujourd'hui que le New England Journal of Medicine (NEJM) a publié les résultats de deux essais cruciaux de phase III, KODIAC-4 ...


Jun 20, 2014, 04:27 ET Im New England Journal Of Medicine veröffentlichte Daten belegen, dass Naloxegol opioidbedingte Obstipation bei chronischen Schmerzpatienten verbessert

AstraZeneca hat heute bekannt gegeben, dass das New England Journal of Medicine (NEJM) Resultate zweier Phase III-Zulassungsstudien veröffentlicht...